Literature DB >> 24865417

Repetitive transcranial magnetic stimulation increases the corticospinal inhibition and the brain-derived neurotrophic factor in chronic myofascial pain syndrome: an explanatory double-blinded, randomized, sham-controlled trial.

Letizzia Dall'Agnol1, Liciane Fernandes Medeiros2, Iraci L S Torres3, Alicia Deitos1, Aline Brietzke1, Gabriela Laste4, Andressa de Souza5, Júlia Lima Vieira6, Felipe Fregni7, Wolnei Caumo8.   

Abstract

UNLABELLED: Chronic myofascial pain syndrome has been related to defective descending inhibitory systems. Twenty-four females aged 19 to 65 years with chronic myofascial pain syndrome were randomized to receive 10 sessions of repetitive transcranial magnetic stimulation (rTMS) (n = 12) at 10 Hz or a sham intervention (n = 12). We tested if pain (quantitative sensory testing), descending inhibitory systems (conditioned pain modulation [quantitative sensory testing + conditioned pain modulation]), cortical excitability (TMS parameters), and the brain-derived neurotrophic factor (BDNF) would be modified. There was a significant interaction (time vs group) regarding the main outcomes of the pain scores as indexed by the visual analog scale on pain (analysis of variance, P < .01). Post hoc analysis showed that compared with placebo-sham, the treatment reduced daily pain scores by -30.21% (95% confidence interval = -39.23 to -21.20) and analgesic use by -44.56 (-57.46 to -31.67). Compared to sham, rTMS enhanced the corticospinal inhibitory system (41.74% reduction in quantitative sensory testing + conditioned pain modulation, P < .05), reduced the intracortical facilitation in 23.94% (P = .03), increased the motor evoked potential in 52.02% (P = .02), and presented 12.38 ng/mL higher serum BDNF (95% confidence interval = 2.32-22.38). No adverse events were observed. rTMS analgesic effects in chronic myofascial pain syndrome were mediated by top-down regulation mechanisms, enhancing the corticospinal inhibitory system possibly via BDNF secretion modulation. PERSPECTIVE: High-frequency rTMS analgesic effects were mediated by top-down regulation mechanisms enhancing the corticospinal inhibitory, and this effect involved an increase in BDNF secretion.
Copyright © 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Myofascial pain syndrome; brain-derived neurotrophic factor; clinical trial; quantitative sensory testing; transcranial magnetic simulation

Mesh:

Substances:

Year:  2014        PMID: 24865417     DOI: 10.1016/j.jpain.2014.05.001

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  25 in total

Review 1.  Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.

Authors:  Andrew F Leuchter; Aimee M Hunter; David E Krantz; Ian A Cook
Journal:  Ann N Y Acad Sci       Date:  2015-03-23       Impact factor: 5.691

2.  High frequency repetitive Transcranial Magnetic Stimulation promotes long lasting phrenic motoneuron excitability via GABAergic networks.

Authors:  Pauline Michel-Flutot; Lyandysha V Zholudeva; Margo L Randelman; Therese B Deramaudt; Arnaud Mansart; Jean-Claude Alvarez; Kun-Ze Lee; Michel Petitjean; Marcel Bonay; Michael A Lane; Stéphane Vinit
Journal:  Respir Physiol Neurobiol       Date:  2021-05-28       Impact factor: 2.821

Review 3.  Non-invasive brain stimulation techniques for chronic pain.

Authors:  Neil E O'Connell; Louise Marston; Sally Spencer; Lorraine H DeSouza; Benedict M Wand
Journal:  Cochrane Database Syst Rev       Date:  2018-04-13

4.  Noninvasive motor cortex stimulation effects on quantitative sensory testing in healthy and chronic pain subjects: a systematic review and meta-analysis.

Authors:  Stefano Giannoni-Luza; Kevin Pacheco-Barrios; Alejandra Cardenas-Rojas; Piero F Mejia-Pando; Maria A Luna-Cuadros; Judah L Barouh; Marina Gnoatto-Medeiros; Ludmilla Candido-Santos; Alice Barra; Wolnei Caumo; Felipe Fregni
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

5.  Combined neuromodulatory interventions in acute experimental pain: assessment of melatonin and non-invasive brain stimulation.

Authors:  Nádia Regina Jardim da Silva; Gabriela Laste; Alícia Deitos; Luciana Cadore Stefani; Gustavo Cambraia-Canto; Iraci L S Torres; Andre R Brunoni; Felipe Fregni; Wolnei Caumo
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

6.  Transcranial Direct Current Stimulation Combined with Aerobic Exercise to Optimize Analgesic Responses in Fibromyalgia: A Randomized Placebo-Controlled Clinical Trial.

Authors:  Mariana E Mendonca; Marcel Simis; Luanda C Grecco; Linamara R Battistella; Abrahão F Baptista; Felipe Fregni
Journal:  Front Hum Neurosci       Date:  2016-03-10       Impact factor: 3.169

Review 7.  Non-invasive brain stimulation techniques for chronic pain.

Authors:  Neil E O'Connell; Louise Marston; Sally Spencer; Lorraine H DeSouza; Benedict M Wand
Journal:  Cochrane Database Syst Rev       Date:  2018-03-16

Review 8.  Transcranial magnetic stimulation of the brain: guidelines for pain treatment research.

Authors:  Max M Klein; Roi Treister; Tommi Raij; Alvaro Pascual-Leone; Lawrence Park; Turo Nurmikko; Fred Lenz; Jean-Pascal Lefaucheur; Magdalena Lang; Mark Hallett; Michael Fox; Merit Cudkowicz; Ann Costello; Daniel B Carr; Samar S Ayache; Anne Louise Oaklander
Journal:  Pain       Date:  2015-09       Impact factor: 7.926

9.  Descending Control of Nociceptive Processing in Knee Osteoarthritis Is Associated With Intracortical Disinhibition: An Exploratory Study.

Authors:  Maria da Graca L Tarragó; Alícia Deitos; Aline Patrícia Brietzke; Rafael Vercelino; Iraci L S Torres; Felipe Fregni; Wolnei Caumo
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

10.  Neuroplastic Effects of Transcranial Direct Current Stimulation on Painful Symptoms Reduction in Chronic Hepatitis C: A Phase II Randomized, Double Blind, Sham Controlled Trial.

Authors:  Aline P Brietzke; Joanna R Rozisky; Jairo A Dussan-Sarria; Alicia Deitos; Gabriela Laste; Priscila F T Hoppe; Suzana Muller; Iraci L S Torres; Mário R Alvares-da-Silva; Rivadavio F B de Amorim; Felipe Fregni; Wolnei Caumo
Journal:  Front Neurosci       Date:  2016-01-11       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.